| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.86▲ | 3.85▲ | 3.86▲ | 4.05▼ | 3.51▲ |
| MA10 | 3.84▲ | 3.89▼ | 3.88▲ | 4.03▼ | 3.11▲ |
| MA20 | 3.85▲ | 3.89▼ | 4.00▼ | 3.72▲ | 2.69▲ |
| MA50 | 3.88▼ | 4.05▼ | 4.01▼ | 3.14▲ | 1.79▲ |
| MA100 | 3.88▼ | 4.04▼ | 3.82▲ | 2.69▲ | 1.67▲ |
| MA200 | 4.00▼ | 3.78▲ | 3.60▲ | 1.96▲ | 1.79▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.002▲ | -0.017▼ | -0.013▼ | 0.104▲ |
| RSI | 55.571▲ | 45.703▼ | 44.941▼ | 55.516▲ | 74.876▲ |
| STOCH | 75.411 | 38.971 | 60.094 | 51.983 | 76.727 |
| WILL %R | -13.043▲ | -38.235 | -48.780 | -52.857 | -25.517 |
| CCI | 82.983 | -32.208 | -23.874 | 3.549 | 113.859▲ |
|
Thursday, November 13, 2025 05:10 AM
CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will ...
|
|
Thursday, November 13, 2025 03:31 AM
One thing we could say about the analysts on CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) - they aren't optimistic, ...
|
|
Tuesday, November 11, 2025 12:04 AM
CytomX Therapeutics, Inc.'s ADC candidate, CX-2051, shows promise in colorectal cancer. Click here to read an analysis of CTMX stock now.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 3.67 | 4.01 | 3.66 | 3.88 | 3,669,963 |
| 13/11/25 | 4.05 | 4.09 | 3.78 | 3.86 | 3,869,053 |
| 12/11/25 | 4.21 | 4.445 | 4.04 | 4.23 | 4,454,577 |
| 11/11/25 | 4.19 | 4.24 | 4.06 | 4.10 | 2,541,427 |
| 10/11/25 | 3.79 | 4.19 | 3.75 | 4.19 | 4,679,652 |
| 07/11/25 | 3.80 | 3.88 | 3.35 | 3.62 | 7,773,576 |
| 06/11/25 | 4.31 | 4.62 | 4.17 | 4.19 | 5,894,247 |
| 05/11/25 | 4.15 | 4.455 | 4.02 | 4.21 | 4,826,843 |
| 04/11/25 | 3.855 | 4.18 | 3.71 | 4.09 | 4,725,930 |
| 03/11/25 | 3.56 | 4.1599 | 3.50 | 3.93 | 10,621,278 |
|
|
||||
|
|
||||
|
|